Market and Trading Information for Synairgen PLC (UK)
The following details are available for trading and market data about the stock of Synairgen PLC as of writing. Currency is GBX.
Trading Details of Synairgen PLC (SNG)
Current Share Price:
GBX 7.20
Previous Year's Closing Price:
GBX 5.97
Percentage Price Change (YTD):
20.60%
Market Cap:
£14.5 million
52-week Price Range:
0 - 17.5
Dividend Per Share:
0
EPS (TTM):
-0.05
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-2.42
Currency:
GBX
Founded/Incorporated:
2005
Company Profile and Business Description for Synairgen PLC
Synairgen plc discovers and develops drugs for respiratory diseases. It develops inhaled interferon beta (IFN-Ã), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-Ã that is in Phase-II clinical trial for the treatment or prevention of chro...to see full details, pleaseLogin / Register to view.
Stock Screener for UK Stocks (Sector-wise)
Peer / Competitor Companies of Biotechnology Sector of UK
Along with Synairgen PLC, the following other peer (competitor) companies also exist within the same Biotechnology - Healthcare sector of United Kingdom whose company profile and dividend history is as follows:
▶ 4Basebio PLC (4BB): 4basebio UK Societas develops gene therapy technologies and solutions primarily in the United Kingdom. It focuses on the manufacture and supply of....See Detailed Company Profile
▶ 4D Pharma Plc (DDDD): 4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development....See Detailed Company Profile
▶ Abcam PLC (ABC): Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the....See Detailed Company Profile
▶ Agronomics Limited (ANIC): Agronomics Limited, formerly known as Port Erin Biopharma Investments Limited, is a principal investment firm specializing in investments in funds, equity and....See Detailed Company Profile
▶ Aptamer Group PLC (APTA): Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The companys binders engineered....See Detailed Company Profile
▶ Arecor Therapeutics PLC (AREC): Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its....See Detailed Company Profile
▶ Arix Bioscience (ARIX): Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage,....See Detailed Company Profile
▶ Avacta Group (AVCT): Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom, North America,....See Detailed Company Profile
▶ Bermele PLC (BERM): Bermele plc intends to acquire business or businesses operating in the pharmaceutical and biotechnology sectors. The company was incorporated in 2017 and is....See Detailed Company Profile
▶ Bioventix Plc (BVXP): Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company....See Detailed Company Profile
▶ Bivictrix Therapeutics PLC (BVX): BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni....See Detailed Company Profile
▶ C4X Discovery Holdings (C4XD): C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom. It has a suite of proprietary technologies across the....See Detailed Company Profile
▶ Circassia Group (CIR): Circassia Group Plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products. It operates through three....See Detailed Company Profile
▶ Cizzle Biotechnology Holdings (CIZ): Cizzle Biotechnology Holdings Plc engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein....See Detailed Company Profile
▶ Collagen Solutions (COS): Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative....See Detailed Company Profile
▶ Destiny Pharma (DEST): Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of....See Detailed Company Profile
▶ Diaceutics PLC (DXRX): Diaceutics Plc provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It offers diagnostic landscape services, such....See Detailed Company Profile
▶ E-Therapeutics (ETX): e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two....See Detailed Company Profile
▶ Ergomed PLC (ERGO): Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in....See Detailed Company Profile
▶ Evgen Pharma (EVG): Evgen Pharma plc, a clinical stage drug development company, engages in developing sulforaphane based medicines for the treatment of multiple diseases. Its....See Detailed Company Profile